Highest development stage: Preclinical

Development dropped

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: Broad spectrum antibiotic which demonstrated potency against H. influenzae, Streptococcus pneumoniae, Moraxella catarrhalis, Yersinia pestis, Bacillus anthracis and MRSA with MIC90 <0.5µg/ml.

Additional information: Fluorocycline